The GDx nerve fibre analyser, photograph courtesy of Zeiss

 

 

The GDx nerve fibre analyser, made by Zeiss, is the most sensitive early screening test for glaucoma available.

 

The following is an extract from the RNIB website:

"Glaucoma

In the UK some form of glaucoma affects about two in 100 people over the age of 40 and five in 100 people over the age of 75. Our research shows that four out of five people have heard of glaucoma but that their understanding is limited, especially about the groups of people who are at higher risk of developing the condition. These are:

bulletpeople of African or Asian origin
bulletpeople with close relatives (father, mother, brother, sister) who have the condition
bulletpeople over 40
bulletpeople with very short sight (severe myopia).

Glaucoma has no symptoms in its early stages and up to 40 per cent of useful sight can be lost before a person realises they have the condition. Regular eye tests are crucial in detecting glaucoma early. Once diagnosed, treatment involves using eye drops and as long as the programme is followed, further sight loss can be minimised."

 

The above shows that early diagnosis is crucial to the preservation of sight.  With the GDx we hope to offer peace of mind to anyone who chooses to have the test done, and the possibility of treatment to anyone found to be in the early stages of the condition. The test does not involve contact with the eye, and takes only a few minutes. 

For a list of our professional fees, please contact us by phone, email or fax or call into the practice.